PF-Atlas › Mechanisms › Prime Editing

Prime Editing in IPF

Mechanism of action · idiopathic pulmonary fibrosis

Overview

Prime Editing is a therapeutic target in idiopathic pulmonary fibrosis. PF-Atlas tracks 1 drug and 1 clinical trial acting through this mechanism.

Drugs targeting Prime Editing

PM-101

Clinical trials

PM-101 — PRIME-AATD
Medical disclaimer. This is a research summary, not medical advice.